|
Tech Transfer eNews is the free online companion to Technology Transfer Tactics monthly newsletter. Enter your email address below and you will receive this weekly electronic newsletter filled with helpful tips, industry news, special reports, and key legal and regulatory updates. Scroll down for this week’s edition.
|
|
|
| Tech Transfer E-News is delivered free every Wednesday. (To enter
your own subscription at no charge, click
here.) It is published by Technology Transfer Tactics independent
monthly newsletter, which itself is available by paid subscription. To
order a subscription click
here, or for a sample review copy at no cost or obligation, click
here.
In this issue:
|
|
U of Ulster’s evaluation license allows trial period to “test
drive” technologies
OpenUlster, a new service recently launched by The University of Ulster,
is an approach to the open innovation model that includes an “evaluation
license.” Operating under a unique trial period arrangement, for
the minimal investment of one Pound the evaluation license allows companies
to “test drive” technologies for a period of three months
to a year before determining whether to proceed with a more formal license
... continue
reading >>>
For about $1 a week, you get so much more!
Here's what's in eNews Platinum Edition
this week
CLICK
HERE to subscribe for only $59!
Here are the extras our Tech Transfer
eNews Platinum Edition subscribers are receiving
today:
- Universities a vital link between science, industry.
A new paper sponsored by the League of European Research
Universities argues that the growth and development of academic
TTOs is a critical factor in building university-industry links
and resulting economic benefits. For that reason, it’s important
to articulate critical success factors that underlie effective
TTO operations. The paper sets out 10 key insights that contribute
to the effectiveness of academic TTOs.
- Consider university’s role in ‘innovation
networks’. In a just-released report, Krisztina
“Z” Holly, vice provost for innovation at the University
of Southern California and founding executive director of the
USC Stevens Institute for Innovation, lays out a compelling case
for the role that U.S. universities play role in driving innovation.
But she also cautions that without policy support that role could
suffer, and she offers five key policy recommendations.
- Computer “grid” capacity helps university
prof boost his invention’s marketability. As this
case study shows, sometimes refining an invention based on feedback
from outside experts or even a sharp group of students can offer
powerful marketing direction, allowing you to fine-tune a technology
so it better meets your prospect’s needs.
- Experience as intern helps TTO exec select ‘next
generation’ of marketers. Tari Suprapto, PhD, assistant
director in The Rockefeller University TTO, believes in “paying
it forward.” Having started her tech transfer career as
an intern at Rockefeller, she now leans on that experience to
inform her decision-making as she chooses her own marketing interns.
PLUS: Subscribers immediately receive these bonuses
valued at more than $750:
- 15% discount on every purchase from our extensive tech transfer
resource catalogue
- A free distance learning program of your choice ($197 value)
- The entire 7-edition Tech Transfer Library, Volume 1 ($399
value)
- A free job listing on our website ($150 value)
Don’t miss another issue – CLICK
HERE to subscribe now now for just $59! |
|
|
PTO announces proposed rules for supplemental examination
Jason Rantanen writes on Patently-O about the USPTO’s
proposed rules for supplemental examinations and proposed revisions to
ex parte reexamination fees. The proposals detail the supplemental examination
process, including the information that requesters must submit, as well
as the substantial fees that will be associated with post-grant review
in the future.
As outlined by Rantanen, major points include ... continue
reading >>>
|
|
Falana v. Kent State University: An important
case on inventorship
In a separate column in Patently-O, Jason Rantanen offers a
case review of Falana v. Kent State University (Fed. Cir. 2012)
Download 11-1198. The case raises an important issue for developers of
chemical compounds: when is an inventor’s contribution to the method
of making a claimed compound an inventive contribution? ... continue
reading >>>
|
|
Build and Manage a Successful Accelerator Fund for Your
University
When it comes to university-based innovations, traditional investors
have become nearly obsessively risk-averse, and getting the backing you
need to commercialize your promising technologies and fund your start-ups
has become a tougher challenge. Creating an in-house accelerator fund
has become a key success strategy for a growing number of TTOs, freeing
up resources that help ensure your high-potential university technologies
get a fair shake -- and the development dollars they need -- to reach
commercial viability. But, establishing a strategic financing structure
within your university technology transfer system or research foundation
can be a risky and daunting task, and requires careful planning as well
as expert execution. That’s why our Distance Learning Division has
scheduled this dynamic and practical webinar featuring two of the world’s
leading TTO financing executives: Build and Manage a Successful
Accelerator Fund for Your University, scheduled for Wednesday,
March 7. Please join Richard S. Schifreen, PhD, who leads
the Accelerator Program at the Wisconsin Alumni Research Foundation, Jonathan
Gortat, coordinator of the Emerging Innovations Fund at Purdue
Research Foundation, for an eye-opening session that will reveal best
practices and offer “how-to” strategies for building and managing
a successful accelerator fund. To register and for complete details, CLICK
HERE.
ALSO COMING SOON:
|
|
Irish universities have a lot to learn about start-ups,
researcher says
Irish business funding for research and university TTOs fails to give
Irish start-up companies the support they need when they need it. Instead,
TTOs tend to take large chunks of company equity in exchange for funding
-- exactly when the companies are most vulnerable -- or drown them in
bureaucracy, according to University College Dublin (UCD) School of Business
lecturer and researcher Rory O’Shea. New models of operation could
free up stale university IP and rejuvenate how research is conducted and
transferred into companies both inside and outside the university, he
says ... continue
reading >>>
|
|
Harvard gets its first VC firm: The Experiment Fund
As just about everyone should know by now, the seeds of what grew into
Facebook were planted at Harvard. Might a bunch of mini-Zucks be lurking
in the dorms of Cambridge? If so, a new venture capital firm -- the first
housed on the Harvard campus -- wants to find them ... continue
reading >>>
|
|
2012 Biotechnology and Medical Device VC Directory released
In this just released 2012 edition of BioWorld Biotechnology
and Medical Device VC Directory, you’ll have crucial
data and intelligence on the world of venture
capital focused on the life sciences. The essential information found
in the international BioWorld Biotechnology and Medical Device
VC Directory 2012 is broken out in profiles and indexes
that arrange the 543 pages of data by:
- Company location
- Investment portfolios
- Companies invested in
- Areas of focus
- Primary contact personnel
- Funding areas/indications
- Stages funded
- Total dollars under management
Having easy access to this critical data can mean the difference between
getting the funding you need to advance your start-up or develop your
technology and seeing it die on the vine from lack of resources. With
the new BioWorld Biotechnology and Medical Device VC Directory
2012, you’ll have access to the information you need
-- covering VCs in the U.S., Canada, Europe, and Asia -- so you can find
the right financial partner and keep your company on solid ground. For
more details and to order, CLICK
HERE.
|
|
Michigan State licenses food safety, security technology
to spinout
Michigan State University has licensed a suite of technologies to detect
a broad range of pathogens and toxins to Michigan-based start-up nanoRETE.
The company was launched by Michigan Accelerator Fund I (MAF-1), an investment
partnership focused on Michigan-based early stage life science and technology
companies ... continue
reading >>>
|
|
UIUC start-up to develop personalized cancer therapeutics
University of Illinois at Urbana-Champaign (UIUC) spinout Vanquish Oncology,
Inc. is focused on targeting molecular defects in specific cancer cells
to create personalized oncology therapeutics for unmet or underserved
cancer markets. The company is focusing on small molecule compounds developed
by Paul Hergenrother, professor in UIUC’s department of chemistry,
that target cell apoptosis across multiple tumor types. Preclinical data
suggest the clinical candidates are well tolerated and efficacious in
rodents and canines. Additionally, the compounds exhibit synergistic effects
when used in combination with common front-line anti-cancer agents ...
continue
reading >>>
|
|
Oxford spinout targets personalized cancer treatment
An Oxford University spinout, Oxford Cancer Biomarkers Ltd. (OCB), is
set to develop technology to ensure that only those patients who are likely
to benefit from anti-cancer drugs will receive them and to identify the
best treatment for each person. Isis Innovation, the university’s
tech transfer company, licensed the CancerNav biomarker technology to
OCB and took an equity stake in the new firm ... continue
reading >>>
|
|
CRT spins out company to develop ultrasound device to
melt tumors
Cancer Research Technology (CRT), the commercial arm of Cancer Research
UK, launched the spinout Acublate Ltd., to develop a next-generation high-intensity
focused ultrasound (HIFU) surgical device to treat a range of solid tumors.
HIFU is a highly precise, noninvasive type of surgery that uses ultrasound
energy to heat and destroy tumors while leaving surrounding healthy tissue
intact. The treatment works with immediate benefit and has the potential
to reduce side effects compared with current alternative treatments ...
continue
reading >>>
|
|
‘Free agency’ tech transfer provisions in
Startup Act raise numerous questions
Fuentek LLC founder and president Laura Schoppe writes on the company’s
blog about the inclusion of the “free agency” concept in Section
7 of the Moran-Warner Startup Act. This idea, originally proposed by the
Kauffman Foundation, allows professors to choose their own agents to help
transfer their technology rather than being tied to their home university’s
TTO. (See previous eNews items here
and here.)
Before such a plan can be implemented, key questions must be addressed,
she says ... continue
reading >>>
|
|
How a start-up can sell products and services to a Fortune
500 company
Rawy Iskander writes on The Tech Entrepreneurship Blog that
selling to a Fortune 500 company is not a walk in the park but
could be key to the long-term success of your start-up. If you have decided
you want a Fortune 500 company as your customer, and strongly
believe you can deliver on your sales promises, keep the following tips
in mind while going through your sales cycle ... continue
reading >>>
|
|
Learn the four ‘catalysts’ start-ups use
to win funding
Benjamin L. Hallen, assistant professor of strategy and entrepreneurship
at London Business School and a contributor to Bloomberg’s Business
Class, says there is a roadmap to venture-fundraising success. Hallen’s
research, in collaboration with Stanford University’s Kathleen Eisenhardt,
identifies four hallmarks of efficient prospecting for money. “By
efficiency we mean attempts that take less than two months of formal,
almost full-time fundraising, while yielding offers from desired investors,”
Hallen writes ... continue
reading >>>
|
|
Stony Brook, Sanofi to collaborate on tuberculosis drug
Stony Brook University has signed a multi-year research collaboration
with Sanofi Aventis Group, of Paris, on a potential treatment for tuberculosis
(TB) and other bacterial infections. The collaboration is based on novel
compounds that inhibit bacterial cell division by interfering with a cellular
protein called FtsZ, which is essential for bacterial cell maintenance
and division. By interfering with FtsZ assembly, the bacteria are unable
to maintain, divide and propagate ... continue
reading >>>
|
|
Contribute to 2012 IP trends survey
What factors affected your TTO’s global IP strategy in 2011? What
is your outlook for 2012? Participate in inovia‘s 3rd annual
U.S. IP Trends
Survey to weigh in. The results, which will be summarized in Tech
Transfer eNews, will provide an in-depth look at the foreign filing
strategy of U.S. patentees and their global outlook for 2012. The survey
takes less than 15 minutes to complete and individual responses are strictly
confidential. Only aggregate, anonymous information will be shared. Click
here to respond
on behalf of your university or organization.
Source: inovia.com
|
|
Submit Your News, Too: If your group has
news of interest to the tech transfer community, submit it for consideration
for publication in Tech Transfer E-News. Email to E-NewsEditor@technologytransfertactics.com
|
| |
|
